China Resources Holdings is considering buying a minority stake in Shanghai Raas Blood Products from Grifols, Manuel Baigorri and Vinicy Chan of Bloomberg report, citing people familiar with the matter. The companies are in talks about a potential transaction that would help Raas cut its debt load, sources told Bloomberg. Other healthcare companies and investment firms have shown interest in acquiring the stake, the people added. Grifols owns a 26% stake in Shanghai Raas, Bloomberg notes.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on GRFS: